Supernus Pharmaceuticals Inc
Closed
SectorHealthcare
41.04 -0.97
Overview
Share price change
24h
Min
41.18
Max
42.47
Income | -56M -58M |
|---|---|
Sales | 11M 219M |
EPS | 0.39 |
Profit margin | -26.646 |
Employees | 778 |
EBITDA | -50M -30M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +57.15% upside |
Next Earnings | 3 lis 2026 |
|---|
Market Cap | -195M 2.5B |
|---|---|
Previous open | 42.01 |
Previous close | 41.04 |
News Sentiment
By Acuity
50%
50%
112 / 339 Ranking in Healthcare
Supernus Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Supernus Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 65.2 USD 57.15%
High 67 USD
Low 63 USD
Based on 5 Wall Street analysts offering 12 month price targets forSupernus Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$